Literature DB >> 339110

Naloxone alters pain perception and somatosensory evoked potentials in normal subjects.

M S Buchsbaum, G C Davis, W E Bunney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 339110     DOI： 10.1038/270620a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  26 in total

1.  Initial aggravation of self-injurious behavior in autistic patients receiving naltrexone treatment.

Authors:  R Knabe; P Schulz; J Richard
Journal:  J Autism Dev Disord       Date:  1990-12

2.  Agonist-antagonist combinations in opioid dependence: a translational approach.

Authors:  P Mannelli
Journal:  Dipend Patologiche       Date:  2010

Review 3.  Anger expression and pain: an overview of findings and possible mechanisms.

Authors:  Stephen Bruehl; Ok Y Chung; John W Burns
Journal:  J Behav Med       Date:  2006-06-29

4.  Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone.

Authors:  David Andrew Tompkins; Ryan K Lanier; Joseph A Harrison; Eric C Strain; George E Bigelow
Journal:  Psychopharmacology (Berl)       Date:  2010-04-13       Impact factor: 4.530

5.  Effects of aspirin, naloxone and placebo.

Authors:  A A Mewa; D Rosenbloom; E M Grace; P Brooks; N Bellamy; C Denko; G Norman; W W Buchanan
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

Review 6.  The genetic mediation of individual differences in sensitivity to pain and its inhibition.

Authors:  J S Mogil
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

7.  Potentiation of pentazocine analgesia by low-dose naloxone.

Authors:  J D Levine; N C Gordon; Y O Taiwo; T J Coderre
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

8.  Opioid peptides.

Authors:  J W Thompson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-28

9.  Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.

Authors:  S M Crain; K F Shen
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

10.  [Psychophysiology of fire walking. II. Pain perception in pyrovasy (fire walking)].

Authors:  C Xenakis; W Holtmann
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.